Urology Specialties, Conditions, Treatments & Technology

Valstar (Valrubicin)

VALSTAR� (valrubicin) is indicated for intravesical therapy of BCG-refractory carcinoma in situ of the urinary bladder in patients for whom immediate cystectomy would be associated with unacceptable morbidity or mortality.

Click the link below to learn more about Valstar – (Valrubicin)

Valstar – (Valrubicin)

Urologic Oncology

Education / Resources

Prostate Cancer Therapeutics

Bladder Cancer Therapeutics


Associated Conditions: